Drug Type Small molecule drug |
Synonyms HP 537, HP-537, HP537 |
Action inhibitors |
Mechanism p300-CBP transcription factors inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseIND Approval |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute Myeloid Leukemia | IND Approval | China | 22 Feb 2024 | |
| Multiple Myeloma | IND Approval | China | 22 Feb 2024 | |
| Myelodysplastic Syndromes | IND Approval | China | 22 Feb 2024 | |
| Hematologic Neoplasms | IND Application | United States | 01 Jun 2025 | |
| Breast Cancer | Preclinical | China | - | |
| Prostatic Cancer | Preclinical | China | - |





